NIT
NBIX icon

NumerixS Investment Technologies’s Neurocrine Biosciences NBIX Stock Holding History

NumerixS Investment Technologies’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,780
Closed -$461K – 537
2020
Q2 		$461K Sell
3,780
-1,600
-30% -$177K 0.13% 181
2020
Q1 		$466K Sell
5,380
-3,320
-38% -$325K 0.24% 90
2019
Q4 		$935K Buy
8,700
+5,800
+200% +$607K 0.18% 119
2019
Q3 		$261K Buy
2,900
+1,700
+142% +$159K 0.07% 314
2019
Q2 		$101K Buy
+1,200
New +$98.5K 0.03% 600
2019
Q1 		– Sell
-3,300
Closed -$226K – 1254
2018
Q4 		$226K Buy
3,300
+1,416
+75% +$136K 0.07% 306
2018
Q3 		$227K Sell
1,884
-216
-10% -$24.5K 0.04% 537
2018
Q2 		$204K Buy
2,100
+1,000
+91% +$89.5K 0.05% 515
2018
Q1 		$91K Buy
+1,100
New +$92.9K 0.02% 685
2017
Q1 		– Sell
-27,200
Closed -$1.05M – 1295
2016
Q4 		$1.05M Buy
27,200
+19,600
+258% +$887K 0.13% 199
2016
Q3 		$385K Sell
7,600
-4,466
-37% -$222K 0.05% 455
2016
Q2 		$548K Buy
12,066
+3,517
+41% +$162K 0.08% 365
2016
Q1 		$338K Buy
+8,549
New +$339K 0.04% 601

Other funds holding NBIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NumerixS Investment Technologies's NBIX Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Neurocrine Biosciences (NBIX) in Q3 2020, closing a stake of 3,780 shares — an estimated $461K sold.

NumerixS Investment Technologies first reported a position in NBIX in Q1 2016 and held it in 13 quarters. The position peaked at $1.05M in Q4 2016. 418 funds tracked by Wall St. Rank hold NBIX as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Neurocrine Biosciences position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 3,780 Neurocrine Biosciences shares in Q3 2020, an estimated $461K.
  • NumerixS Investment Technologies first reported a position in Neurocrine Biosciences in Q1 2016 and held it in 13 quarters.
  • NumerixS Investment Technologies's Neurocrine Biosciences position peaked at $1.05M in Q4 2016.
  • 418 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.